Figure 4.

Phenotypic assessment of hiPSC-derived HPCs

(A) Representative overlay showing expression of hematopoietic progenitor cell marker CD34 across 3 genetically independent hiPSC-derived cells lines at day 14 in floating HPCs (Average = 86.5%, N = 3).

(B) Representative overlay showing expression of leukocyte marker CD45 across 3 genetically independent hiPSC-derived cells lines at day 14 in floating HPCs (Average = 93.7%, N = 3). Expression from staining with the appropriate isotype antibodies is shown as negative control for all groups (gray).